Read news as it happens
Create a Rediffmail account
Get Rediff News delivered into your Inbox daily
Desi medical devices firms fight global cos with aggressive pricing
Welcome to India's medical devices companies which are successfully locking horns with global giants, whether in...
Quality perceptions hobble Jan Aushadi drugs
Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of...
Shivinder vs Malvinder: Mother helps avoid legal battle for now
Sources said she had stopped eating for the past few days and had constantly been making calls and sending emails to...
How Allergan plans to boost Botox sales in Indian market
While the Botox segment is growing annually at around 20-25% in the country, Allergan India's aesthetics business is...
Why drug firms' Q2 revenue growth is likely to dip
Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian...
Dr Reddy's sells US facility to UAE-based Neopharma
The plant and associated facilities focus on manufacturing or packaging Amoxicilin-based products, which include...
328 fixed-dose combination drugs banned on safety grounds
The original list had named 349 drugs, but 15 drugs, approved prior to 1988, have been kept outside the purview of...
Dr Reddy's A-team moves on putting house in order
After spending considerable time and energy in remediation efforts in the wake of the US Food and Drug...
For Singh brothers, truce is temporary, split only way out
NCLT allows Shivinder to withdraw petition against his brother Malvinder. Final decision to be taken by family...
Govt takes steps to regulate e-pharmacies
Under the proposed rules, individuals or companies will have to register with the central licensing authority to run...
Office email App
© 2018 Rediff.com